Literature DB >> 34257496

Ischemia and No Obstructive Coronary Artery Disease and Pulmonary Hypertension in a 16-Year-Old Girl with Unquenched Hyperthyroidism of Graves' Disease.

Meng-Luen Lee1,2, Ming-Che Chang3,4, Yu-Mei Wang5.   

Abstract

Entities:  

Year:  2021        PMID： 34257496      PMCID： PMC8261692          DOI： 10.6515/ACS.202107_37(4).20210212A

Source DB:  PubMed          Journal:  Acta Cardiol Sin        ISSN： 1011-6842            Impact factor:   2.672


× No keyword cloud information.
  19 in total

1.  A unique case of reversible myocardial ischemia in a hyperthyroid neonate.

Authors:  Christina Trapali; Heracles D Dellagrammaticas; Angeliki Nika; Nicoletta Iacovidou
Journal:  Pediatr Cardiol       Date:  2007-10-03       Impact factor: 1.655

Review 2.  The crosstalk between thyroid hormones and the Renin-Angiotensin System.

Authors:  Maria Luiza M Barreto-Chaves; Maria Alícia Carrillo-Sepúlveda; Marcela S Carneiro-Ramos; Dayane A Gomes; Gabriela P Diniz
Journal:  Vascul Pharmacol       Date:  2009-10-24       Impact factor: 5.773

3.  Concurrence of Persistent Pulmonary Hypertension of the Newborn, Myocardial Ischemia, Supraventricular Tachycardia, and Congestive Heart Failure as a Harbinger of Neonatal Graves' Disease.

Authors:  Meng-Luen Lee; Yu-Mei Wang; Ming-Che Chang
Journal:  Acta Cardiol Sin       Date:  2020-05       Impact factor: 2.672

Review 4.  Autoimmunity and pulmonary hypertension: a perspective.

Authors:  M R Nicolls; L Taraseviciene-Stewart; P R Rai; D B Badesch; N F Voelkel
Journal:  Eur Respir J       Date:  2005-12       Impact factor: 16.671

5.  Integrating noninvasive absolute flow, coronary flow reserve, and ischemic thresholds into a comprehensive map of physiological severity.

Authors:  Nils P Johnson; K Lance Gould
Journal:  JACC Cardiovasc Imaging       Date:  2012-04

6.  Autoimmune thyroid disease in children and adolescents with idiopathic pulmonary arterial hypertension.

Authors:  Mari Satoh; Keiko Aso; Tomotaka Nakayama; Kazuyuki Naoi; Satoshi Ikehara; Yumiko Uchino; Hiromitsu Shimada; Shinichi Takatsuki; Hiroyuki Matsuura; Tsutomu Saji
Journal:  Circ J       Date:  2009-12-15       Impact factor: 2.993

Review 7.  Coronary microvascular dysfunction in the clinical setting: from mystery to reality.

Authors:  Joerg Herrmann; Juan Carlos Kaski; Amir Lerman
Journal:  Eur Heart J       Date:  2012-08-22       Impact factor: 29.983

8.  Thyroid hormone is highly permissive in angioproliferative pulmonary hypertension in rats.

Authors:  Aysar Al Husseini; Gianluca Bagnato; Laszlo Farkas; Jose Gomez-Arroyo; Daniela Farkas; Shiro Mizuno; Donatas Kraskauskas; Antonio Abbate; Benjamin Van Tassel; Norbert F Voelkel; Harm Jan Bogaard
Journal:  Eur Respir J       Date:  2012-07-26       Impact factor: 16.671

9.  Cardiac microvascular rarefaction in hyperthyroidism-induced left ventricle dysfunction.

Authors:  Felipe Freitas; Vanessa Estato; Vinícius Frias Carvalho; Rafael Carvalho Torres; Marcos Adriano Lessa; Eduardo Tibiriçá
Journal:  Microcirculation       Date:  2013-10       Impact factor: 2.628

10.  Systemic microvascular dysfunction in microvascular and vasospastic angina.

Authors:  Thomas J Ford; Paul Rocchiccioli; Richard Good; Margaret McEntegart; Hany Eteiba; Stuart Watkins; Aadil Shaukat; Mitchell Lindsay; Keith Robertson; Stuart Hood; Eric Yii; Novalia Sidik; Adam Harvey; Augusto C Montezano; Elisabeth Beattie; Laura Haddow; Keith G Oldroyd; Rhian M Touyz; Colin Berry
Journal:  Eur Heart J       Date:  2018-12-07       Impact factor: 29.983
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.